| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |